Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating […]
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating […]
